July 16, 2020
Westlaw Journal Intellectual Property
Although a party need not have Article III standing to appear before the Patent Trial and Appeal Board (PTAB), it must establish standing when appealing an adverse PTAB decision to the Federal Circuit. Building on the reasoning in a line of cases following GE, JTEKT, and AVX, the Federal Circuit has further elaborated on the particular standing requirements a party must meet to maintain an appeal. For instance, recently in Pfizer, Argentum, and Grit Energy, the Court closely examined the evidence required to show injury based on economic harm or infringement risk, and stressed that the appellant must prove that standing exists at the outset of the appeal and at all later stages.
In this article, Finnegan attorneys Mike Flibbert and Michelle Rice review the Federal Circuit’s analysis in recent standing cases, and provide practical considerations for parties seeking to establish, or refute, standing to appeal PTAB decisions.
Read the full article here.
©2020 Thomson Reuters. Originally published by Westlaw Journal Intellectual Property. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
At the PTAB Blog
June 18, 2026
Lecture
Latest Developments in U.S. Section 337 Investigations and Response Strategies
June 12, 2026
Dongguan
Federal Circuit IP Blog
Federal Circuit Reinforces Injury-in-Fact Requirement in Appeals from Post-Grant Proceedings
June 10, 2026
At the PTAB Blog
IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026
May 26, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.